Join host Jim Wilson for a conversation with Dylan Horvath, founder and principal of Cortex Design in Toronto, Ontario.

Cortex helps MedTech teams take medical devices from early concept through to commercialization, with a focus on designing for real users and the full set of stakeholders who influence adoption.

Dylan shares how a childhood obsession with robotics led him into systems design engineering, then into industrial design, and ultimately into building Cortex into a specialized MedTech practice. They talk about the high-stakes Qualcomm Tricorder XPRIZE experience, what it taught the team about focus and execution, and why usability, workflow, and practical realities like cleaning and procurement can determine whether a device succeeds in the market.

This episode offers a clear look at what it takes to turn complex ideas into viable, commercial medical products.

In this episode of NGBi Lab, host Jim Wilson welcomes Loreen Wales, the Founder and CEO of Revive Wellness and My Viva.

Discover the harrowing origin story that fueled Loreen's mission: a near-fatal accident at age 19 that left her with a miracle survival and a relentless drive to transform how we deliver patient care.

From her early days as a dietitian in Edmonton to realizing that the healthcare system lacked a personalized, scalable plan for patients, Loreen discusses her 18-year journey of building a holistic digital health platform.

From the grit required to transition from a "bricks and mortar" clinic to a global technology company, to the reality of a "10-year overnight success," this conversation dives into the conviction and risk required to innovate in the health sciences sector.

In this episode of NGBi Lab, host Jim Wilson welcomes Akeem Gardner, CEO and Founder of Canurta Therapeutics. Discover how Akeem transitioned from law school and farming into the biotech space to build a company developing botanical drug candidates for neurodegenerative diseases, with a lead program targeting ALS.

From his unconventional entrepreneurial journey and the shift from ingredient supplier to full biotechnology company, to the stark financial realities of funding clinical trials, this conversation dives deep into the conviction and risk required to innovate in the life sciences sector.

Tune in to learn about his vision for Canurta Therapeutics and what it really takes to run a startup.